Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

330 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.
Boero S, Morabito A, Banelli B, Cardinali B, Dozin B, Lunardi G, Piccioli P, Lastraioli S, Carosio R, Salvi S, Levaggi A, Poggio F, D'Alonzo A, Romani M, Del Mastro L, Poggi A, Pistillo MP. Boero S, et al. Among authors: romani m. J Transl Med. 2015 Oct 8;13:324. doi: 10.1186/s12967-015-0680-0. J Transl Med. 2015. PMID: 26450443 Free PMC article.
Erratum to: Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.
Boero S, Morabito A, Banelli B, Cardinali B, Dozin B, Lunardi G, Piccioli P, Lastraioli S, Carosio R, Salvi S, Levaggi A, Poggio F, D'Alonzo A, Romani M, Del Mastro L, Poggi A, Pistillo MP. Boero S, et al. Among authors: romani m. J Transl Med. 2016 Jan 22;14:24. doi: 10.1186/s12967-016-0779-y. J Transl Med. 2016. PMID: 26801979 Free PMC article. No abstract available.
A novel multiplex pyrosequencing assay for genotyping functionally relevant CTLA-4 polymorphisms: potential applications in autoimmunity and cancer.
Banelli B, Morabito A, Laurent S, Piccioli P, Dozin B, Ghio M, Ascierto PA, Monteghirfo S, Marasco A, Ottaviano V, Queirolo P, Romani M, Pistillo MP. Banelli B, et al. Among authors: romani m. Hum Immunol. 2014 Aug;75(8):730-9. doi: 10.1016/j.humimm.2014.04.019. Epub 2014 May 5. Hum Immunol. 2014. PMID: 24801647
CTLA-4 in mesothelioma patients: tissue expression, body fluid levels and possible relevance as a prognostic factor.
Roncella S, Laurent S, Fontana V, Ferro P, Franceschini MC, Salvi S, Varesano S, Boccardo S, Vigani A, Morabito A, Canessa PA, Giannoni U, Rosenberg I, Valentino A, Fedeli F, Merlo DF, Ceppi M, Riggio S, Romani M, Saverino D, Poggi A, Pistillo MP. Roncella S, et al. Among authors: romani m. Cancer Immunol Immunother. 2016 Aug;65(8):909-17. doi: 10.1007/s00262-016-1844-3. Epub 2016 May 20. Cancer Immunol Immunother. 2016. PMID: 27207606 Free PMC article.
Response to ipilimumab therapy in metastatic melanoma patients: potential relevance of CTLA-4+ tumor infiltrating lymphocytes and their in situ localization.
Mastracci L, Fontana V, Queirolo P, Carosio R, Grillo F, Morabito A, Banelli B, Tanda E, Boutros A, Dozin B, Gualco M, Salvi S, Romani M, Spagnolo F, Poggi A, Pistillo MP. Mastracci L, et al. Among authors: romani m. Cancer Immunol Immunother. 2020 Apr;69(4):653-662. doi: 10.1007/s00262-020-02494-y. Epub 2020 Feb 5. Cancer Immunol Immunother. 2020. PMID: 32025849 Free PMC article.
Epigenetic Targeting of Glioblastoma.
Romani M, Pistillo MP, Banelli B. Romani M, et al. Front Oncol. 2018 Oct 16;8:448. doi: 10.3389/fonc.2018.00448. eCollection 2018. Front Oncol. 2018. PMID: 30386738 Free PMC article. Review.
Immune Checkpoints and Innovative Therapies in Glioblastoma.
Romani M, Pistillo MP, Carosio R, Morabito A, Banelli B. Romani M, et al. Front Oncol. 2018 Oct 23;8:464. doi: 10.3389/fonc.2018.00464. eCollection 2018. Front Oncol. 2018. PMID: 30406030 Free PMC article. Review.
330 results